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In the print version of the article listed above, the third and fourth labels on the top of [Figure 2](#F2){ref-type="fig"} and the third and fourth labels on the top and bottom of [Figure 3](#F3){ref-type="fig"} are incorrect. The correct figures appear below. The online version reflects these changes.

![Glomerular mesangial expansion and thickening of basement membrane were reduced by treatment with human recombinant ACE2. *A--C*: Representative light micrographs of periodic acid Schiff--stained kidney sections from each group of mice (magnification ×630) (*A*) with quantification of the glomerular volume (*C*) showing glomerular expansion in the diabetic Akita mice and a marked reduction in response to hrACE2. *B* and *D*: Transmission electron microscopy of the glomeruli (*B*) with quantification of the glomerular basement thickness (*D*) showing increased glomerular basement membrane thickness in the Akita *Ins2*^WT/C96Y^ mice, which was normalized by treatment with hrACE2. White arrows indicate the glomerular basement membrane. *E*: Mesangial matrix expansion score showing increased mesangial expansion in diabetic Akita kidneys, which was prevented by hrACE2. *n* = 5 for all groups. \**P* \< 0.05 compared with all other groups and \#*P* \< 0.05 compared with placebo + *Ins2*^WT/WT^ group using ANOVA with multiple comparison testing. (A high-quality digital representation of this figure is available in the online issue.)](zdb0041061120002){#F2}

![Increased glomerular expression of α-SMA and collagen III in the diabetic Akita kidneys without evidence of inflammatory changes in response to human recombinant ACE2. *A--D*: Increased glomerular immunostaining for α-SMA (*A*) and collagen III (*B*) in diabetic Akita mice that was quantified based on computer image analysis scores of glomerular immunostaining of α-SMA (*C*) and collagen III (*D*). Positive controls are shown as staining in renal blood vessels for α-SMA and from a kidney after 14 days of ureteral obstruction for collagen III. *n* = 5 for all groups. \**P* \< 0.01 compared with all other groups using ANOVA and multiple comparison testing. *E* and *F*: Immunohistochemical-specific staining of neutrophil and macrophage revealed no evidence of inflammation in the diabetic Akita mice without a differential impact with treatment with hrACE2. Positive controls were taken from mouse spleen and lung tissue. Scale bar, 100 μm. (A high-quality digital representation of this figure is available in the online issue.)](zdb0041061120003){#F3}
